Kingdon Capital Management »

Syndax Pharmaceuticals shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $18M 895k 20.53
2024-03-31 $21M 895k 23.80
2023-12-31 $16M 746k 21.61

More positions owned by Kingdon Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Insmed Com Par $.01 Call Option (INSM)
Visa Com Cl A (V)
Select Sector Spdr Tr Financial Put Option (XLF)
Ftai Aviation SHS (FTAI)
Api Group Corp Com Stk (APG)
Bank of America Corporation Call Option (BAC)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Russell 2000 Etf Put Option (IWM)
UnitedHealth (UNH)
Meta Platforms Cl A Put Option (META)
Guardant Health (GH)
Advanced Micro Devices (AMD)
Tenet Healthcare Corp Com New (THC)
Syndax Pharmaceuticals (SNDX)

View all positions for Kingdon Capital Management

Top funds holding Syndax Pharmaceuticals

BlackRock
BlackRock
Kynam Capital Management
Vanguard Group
State Street Corporation
Point72 Asset Management
Avidity Partners Management
Geode Capital Management
Stempoint Capital
OrbiMed Advisors
Woodline Partners
Franklin Resources
Goldman Sachs Group
First Turn Management
Aisling Capital Management

View all funds holding Syndax Pharmaceuticals